Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help pave the way for more personalized treatments for sarcopenia in people with end-stage liver disease. The research was led by scientists at the University of Birmingham and published in the Journal of Cachexia, Sarcopenia and Muscle. The study reveals for the first time that the underlying cause of liver disease shapes how muscle loss develops and how it may respond to treatment.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗